Financhill
Buy
53

GNMSF Quote, Financials, Valuation and Earnings

Last price:
$325.00
Seasonality move :
-5%
Day range:
$313.60 - $313.60
52-week range:
$170.00 - $336.45
Dividend yield:
0%
P/E ratio:
13.34x
P/S ratio:
5.50x
P/B ratio:
3.36x
Volume:
306
Avg. volume:
1.2K
1-year change:
54.23%
Market cap:
$19.3B
Revenue:
$3.1B
EPS (TTM):
$23.50

Earnings Data

Next earnings date for GNMSF
Feb 05
2026
Most recent earnings per share
$6.46
Beat by $6.46
(Nov 6/2025)
Consensus Estimate
--
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

GNMSF Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/05/2026 Q4 $1B -- -- -- --
11/06/2025 Q3 $987.6M $1B $6.46 -- --
08/07/2025 Q2 $902.1M $925M $5.46 -- --
05/08/2025 Q1 $759.6M $715M $3.05 -- --
02/12/2025 Q4 $898.3M $921.1M $8.53 -- --
11/06/2024 Q3 $819.2M $815.7M $2.94 -- --
08/08/2024 Q2 $723.6M $775.5M $3.12 -- --
05/02/2024 Q1 $572.3M $603.5M $2.94 -- --
02/14/2024 Q4 $667.6M $686.8M $1.53 -- --
11/07/2023 Q3 -- -- $4.72 -- --
08/03/2023 Q2 -- -- $3.01 -- --
05/10/2023 Q1 -- -- $0.49 -- --
12/31/2022 Q4 -- -- $1.21 -- --
11/09/2022 Q3 -- -- $5.30 -- --
08/10/2022 Q2 -- -- $4.10 -- --
05/11/2022 Q1 -- -- $1.06 -- --
02/16/2022 Q4 -- -- $1.66 -- --
11/10/2021 Q3 -- -- $2.14 -- --
08/11/2021 Q2 -- -- $0.75 -- --
05/05/2021 Q1 -- -- $2.69 -- --
02/23/2021 Q4 -- -- $1.40 -- --
11/04/2020 Q3 -- -- $1.26 -- --
08/12/2020 Q2 -- -- $7.58 -- --
05/06/2020 Q1 -- -- $0.60 -- --
12/31/2019 Q4 -- -- $3.41 -- --
09/30/2019 Q3 -- -- $1.23 -- --

Genmab A/S Earnings Questions

  • How Much did Genmab A/S Generate in Revenue Last Quarter?

    Genmab A/S reported $1B worth of top line sales in its most recent quarter.

  • Did Genmab A/S Beat Earnings Last Quarter?

    Genmab A/S announced earnings per share of $6.46 which represents a beat of analyst forecast a -- per share.

  • Is Genmab A/S Profitable?

    Genmab A/S reported $964M that represents $15.53 per share over the last quarter.

  • What is the Analyst Consensus for Genmab A/S EPS Next Year?

    Genmab A/S's earnings are forecast to grow from $17.60 per share to -- per share next year representing an increase of --.

  • When is Genmab A/S's Earnings Date?

    Genmab A/S's next earnings date is February 5, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Is Berkshire Hathaway Stock Undervalued?
Is Berkshire Hathaway Stock Undervalued?

Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…

Is Oracle Stock Undervalued?
Is Oracle Stock Undervalued?

Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…

Stock Ideas

Sell
49
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 59x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
55
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 38x

Alerts

Sell
35
SMX alert for Dec 19

SMX (Security Matters) Plc [SMX] is up 11.91% over the past day.

Sell
36
INSP alert for Dec 19

Inspire Medical Systems, Inc. [INSP] is up 1.39% over the past day.

Sell
40
INSM alert for Dec 19

Insmed, Inc. [INSM] is up 4.79% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock